COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA
机构：[1]IQVIA, Shanghai, China,[2]Humanities College, Shanghai Institute of Technology, Shanghai, China,[3]Shanghai General Hospital, Shanghai, China,[4]Peking University People’s Hospital, Beijing, China,[5]Xijing Hospital, Fourth Military Medical University, Xi’an, China,[6]Peking Union Medical College Hospital, Beijing, China,[7]Beijing Tongren Hospital, Capital Medical University, Beijing, China,首都医科大学附属北京同仁医院首都医科大学附属同仁医院[8]Bayer Healthcare Company Ltd., Beijing, China,[9]Fudan University, Shanghai, China
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2018]版：
大类|2 区医学
小类|2 区卫生保健与服务
最新[2023]版：
大类|2 区医学
小类|2 区经济学2 区卫生保健与服务2 区卫生政策与服务
JCR分区：
出版当年[2017]版：
Q1HEALTH CARE SCIENCES & SERVICESQ1ECONOMICSQ1HEALTH POLICY & SERVICES
最新[2023]版：
Q1ECONOMICSQ1HEALTH CARE SCIENCES & SERVICESQ1HEALTH POLICY & SERVICES
Ming J.,Zhang Y.,Xu X.,et al.COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA[J].VALUE IN HEALTH.2019,22:S580-S580.
APA：
Ming, J.,Zhang, Y.,Xu, X.,Zhao, M.,Wang, Y....&Hu, S..(2019).COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA.VALUE IN HEALTH,22,
MLA：
Ming, J.,et al."COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA".VALUE IN HEALTH 22.(2019):S580-S580
